Itch inhibition regulates chemosensitivity in vitro

被引:43
作者
Hansen, T. M.
Rossi, M.
Roperch, J. P.
Ansell, K.
Simpson, K.
Taylor, D.
Mathon, N.
Knight, R. A.
Melino, G.
机构
[1] Univ Leicester, Toxicol Unit, MRC, Leicester LE1 9HN, Leics, England
[2] MRC Technol, Drug Discovery Grp, London NW7 1AD, England
基金
英国医学研究理事会;
关键词
itch; p73; p63; p53; chemosensitivity; E3; ligase; protein degradation; proteasome; drug discovery;
D O I
10.1016/j.bbrc.2007.06.104
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Itch is a member of the HECT family of ubiquitin E3 ligases, and regulates the stability of several proteins involved in response to genotoxic stress. We have previously shown that p73 and p63, two members of the p53 family of tumour suppressors, are targets for Itch-mediated ubiquitylation and degradation. Here, we show that depletion of Itch by RNA interference augments apoptosis upon treatment with chemotherapeutic drugs. We also show that cells with no functional p53 are more sensitive to Itch depletion, highlighting the importance that changes in levels of Itch may play in majority of cancers, where p53 is absent or mutated. Furthermore, reintroduction of Itch in fibroblasts obtained from Itch deficient mice results in reduced cell death upon DNA damage. Overall our findings suggest that inhibition of Itch potentiates the effect of chemotherapeutic drugs revealing the pharmacological potentials of targeting Itch for cancer therapy. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:33 / 36
页数:4
相关论文
共 15 条
  • [1] Agami R, 1999, NATURE, V399, P809
  • [2] The E3 ubiquitin ligase itch couples JNK activation to TNFα-induced cell death by inducing c-FLIPL turnover
    Chang, LF
    Kamata, H
    Solinas, G
    Luo, JL
    Maeda, S
    Venuprasad, K
    Liu, YC
    Karin, M
    [J]. CELL, 2006, 124 (03) : 601 - 613
  • [3] Dysregulation of T lymphocyte function in itchy mice:: a role for itch in TH2 differentiation
    Fang, DY
    Elly, C
    Gao, BX
    Fang, N
    Altman, Y
    Joazeiro, C
    Hunter, T
    Copeland, N
    Jenkins, N
    Liu, YC
    [J]. NATURE IMMUNOLOGY, 2002, 3 (03) : 281 - 287
  • [4] Tumor predisposition in mice mutant for p63 and p73:: Evidence for broader tumor suppressor functions for the p53 family
    Flores, ER
    Sengupta, S
    Miller, JB
    Newman, JJ
    Bronson, R
    Crowley, D
    Yang, A
    McKeon, F
    Jacks, T
    [J]. CANCER CELL, 2005, 7 (04) : 363 - 373
  • [5] Jun turnover is controlled through JNK-dependent phosphorylation of the E3 ligase itch
    Gao, M
    Labuda, T
    Xia, Y
    Gallagher, E
    Fang, D
    Liu, YC
    Karin, M
    [J]. SCIENCE, 2004, 306 (5694) : 271 - 275
  • [6] Gong JG, 1999, NATURE, V399, P806
  • [7] Chemosensitivity linked to p73 function
    Irwin, MS
    Kondo, K
    Marin, MC
    Cheng, LS
    Hahn, WC
    Kaelin, WG
    [J]. CANCER CELL, 2003, 3 (04) : 403 - 410
  • [8] HUMAN PAPILLOMAVIRUS-16 E6 EXPRESSION DISRUPTS THE P53-MEDIATED CELLULAR-RESPONSE TO DNA DAMAGE
    KESSIS, TD
    SLEBOS, RJ
    NELSON, WG
    KASTAN, MB
    PLUNKETT, BS
    HAN, SM
    LORINCZ, AT
    HEDRICK, L
    CHO, KR
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (09) : 3988 - 3992
  • [9] Overexpression of p73 enhances cisplatin-induced apoptosis in HeLa cells
    Kim, KC
    Jung, CS
    Choi, KH
    [J]. ARCHIVES OF PHARMACAL RESEARCH, 2006, 29 (02) : 152 - 158
  • [10] p73: Friend or foe in tumorigenesis
    Melino, G
    De Laurenzi, V
    Vousden, KH
    [J]. NATURE REVIEWS CANCER, 2002, 2 (08) : 605 - 615